Tuesday 3 November 2026International EditionRSSMembers
The financial daily of the startup economy
MarketsMembers

Accelevation prices below its range, and sponsor-backed exits learn the cost of selling

The data centre supplier sold shares at $18, under a $20 to $24 range, with two thirds of the offering going to its private equity owner. Buyers paid for growth but priced in the structure.

Pop-art illustration for: Accelevation prices below its range, and sponsor-backed exits learn the cost of selling
Illustration: Invest Times

Accelevation Holdings, an Ohio maker of power and structural equipment for data centres, priced its initial public offering on Tuesday, September 29, at $18 a share, below the $20 to $24 range it had marketed to investors. It sold 30 million Class A shares for $540 million in total. Only 10 million of those shares were new, raising $180 million for the company. The other 20 million were sold by affiliates of Olympus Partners, the private equity firm that took control of the business on January 2, 2025. The stock began trading on the Nasdaq Global Select Market under the ticker ACCV on Wednesday and opened at $17.55, below the offer price.

The deal had been billed as a test of investor appetite for the AI infrastructure trade, and the result was a qualified pass. The book was filled, but only after the price came down by about 18% from the midpoint of the range. In the same week, the smart ring maker Oura postponed a larger offering that was also weighted towards selling shareholders. Read together, the two decisions show what public investors will and will not pay for in the current window, and that matters to every venture and buyout fund planning an exit before year end.

A fast-growing business with a sponsor's balance sheet

The operating story is strong. According to the final prospectus filed with the Securities and Exchange Commission on October 1, revenue rose to $447.8 million in 2025 from $181.4 million in 2024, an increase of 147%. In the first six months of 2026 it reached $437.5 million, up 175.8% on the same period a year earlier and almost equal to the whole of the previous year. Backlog stood at about $1.1 billion at the end of June. The company traces its revenue from under $3 million in 2021, the year it launched its data centre business, to a business with seven manufacturing plants in Ohio, Tennessee, Mississippi and Virginia.

The quality of that growth is less clear cut. Gross profit in the first half of 2026 was $116.2 million, a gross margin of about 26.6%, compared with roughly 30.4% in the first half of 2025 and 32.3% for the full year 2025. Net income in the first half was $19.3 million. Free cash flow, as the company defines it, was negative at minus $15.8 million, after minus $16.4 million in 2025. The prospectus says no single customer accounted for more than 45% of revenue in 2025, which is another way of saying that one customer came close to half.

The balance sheet carries the marks of private equity ownership. At June 30 the company owed about $651.5 million under its term loan, at a weighted average interest rate of roughly 8.8%. On June 25, three months before the listing, it borrowed $346.0 million of new term loans, and the prospectus states that the money was used mainly to fund a distribution of $299.4 million to certain members. The company plans to use its share of the IPO proceeds to repay about $170.6 million of that debt.

Who gets the money

Put the pieces together and the flow of cash is plain. Olympus affiliates received $360 million in gross proceeds from the shares they sold, after a June distribution to members of which they were the principal holder. The company's own $180 million, before fees, goes largely to lenders. New shareholders are, in effect, refinancing a dividend recapitalisation while buying a minority stake.

They are also buying into an Up-C structure with a tax receivable agreement. Under that arrangement, the listed holding company will pay entities controlled by Olympus a share of certain tax benefits it may realise, and the prospectus warns that those payments are expected to be substantial and could materially affect liquidity. After the offering Olympus will control about 85% of the combined voting power, or 83% if the underwriters exercise their option to buy 4.5 million more shares, which makes Accelevation a controlled company under Nasdaq rules and exempts it from the requirement to have a majority of independent directors. Existing holders have agreed to a 180-day lock-up.

None of this is unusual for a sponsor-backed listing, and all of it is disclosed. But it explains why the price moved. Bloomberg's calculation, cited by Oninvest, put the market value at about $4 billion at the offer price. Investors who accepted that figure for a company growing at triple-digit rates still demanded a discount for thin free cash flow, a controlling shareholder and a debt load built partly to pay that shareholder.

The window is open, but selective

Accelevation was not the only deal tested this week. At the start of the week Oura said it was postponing its Nasdaq offering because of uncertainty in the IPO market, despite what it described as strong demand. According to Renaissance Capital, Oura had sought $2.1 billion by selling 50 million shares at $40 to $44, with 73% of the shares coming from existing holders. TechCrunch reported that the midpoint of the range would have valued the company at up to $15 billion, that early backer Forerunner Ventures had planned to sell its entire 9.3% stake, and that most of the company's own proceeds were meant to cover taxes on employee share awards vesting at the listing. Chief executive Tom Hale said the company had the luxury of choosing its moment.

The common feature is the share of the offering going to existing owners. Accelevation's deal was two thirds secondary and Oura's nearly three quarters. Accelevation, which needed the listing to begin deleveraging and to give its sponsor a route to further sales, accepted the market's price. Oura, which held about $372 million in cash at the end of June according to TechCrunch, chose to wait.

There is still demand for the theme. Oninvest noted that Forgent Power Solutions, a listed competitor, had risen by about 40% since its February IPO. Investors are willing to own the suppliers of the AI build-out. What they are no longer doing is paying the top of a range simply because the label is attractive.

Lessons for startup and sponsor exits

For venture-backed companies the lesson is about the mix of primary and secondary shares. An offering in which most of the money leaves with existing holders invites buyers to ask why insiders are selling now, and in this market they answer that question with price. Companies that raise meaningful primary capital for growth, and can show it, are better placed to defend a range.

For buyout firms the lesson is about sequencing. A dividend recapitalisation shortly before an IPO is a legitimate tool, but it shifts leverage onto the public balance sheet and reduces the room for a first-day premium. Sponsors that have already taken cash out should expect new shareholders to want a larger margin of safety.

For limited partners waiting for distributions, the Accelevation result is good news in one respect: a $540 million deal cleared. The 18% haircut to the midpoint is the price of clearing it.

Our view

Accelevation got its deal done, and for Olympus the arithmetic works. A debt-funded distribution of almost $300 million to members in June, followed by $360 million from selling shares in the IPO, while keeping about 85% of the votes, is an efficient partial exit. Public investors were not fooled by it. They paid for the growth and backlog but cut the price for weak cash conversion, falling gross margins and a governance structure that leaves them with little say.

That is a healthy outcome for a market that has been accused of indiscipline on AI infrastructure. The message for founders and their backers is that the window rewards substance and charges for structure. Heavily secondary offerings, controlled-company status and tax receivable agreements are not deal breakers, but each one now has a visible cost.

What to watch: whether Accelevation can hold the $18 price as the stabilisation period ends, whether its next quarterly report shows gross margins recovering, and whether Oura and other postponed issuers return with smaller secondary components.

Sources

Filed under Markets. Written by Invest Times Editorial under our editorial standards. Commentary and analysis for information only, not investment advice.